Cleared Traditional

K950798 - POSTERIOR CAPSULE SHIELD

K950798 is an FDA 510(k) clearance for POSTERIOR CAPSULE SHIELD, manufactured by Oasis Medical, Inc.. The device is a Class 2 Ophthalmic device with product code HQC cleared through the Traditional 510(k) pathway after a 90-day FDA review.

K950798 · Oasis Medical, Inc. · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1995
Decision
90d
Days
Class 2
Risk

K950798 is an FDA 510(k) clearance for the POSTERIOR CAPSULE SHIELD. Classified as Unit, Phacofragmentation (product code HQC), Class II - Special Controls.

Submitted by Oasis Medical, Inc. (Glendora, US). The FDA issued a Cleared decision on May 22, 1995 after a review of 90 days - within the typical 510(k) review window.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4670 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Ophthalmic review framework, consistent with the majority of Class II 510(k) submissions.

View all Oasis Medical, Inc. devices

FDA 510(k) Submission Details - K950798

510(k) Number K950798 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 21, 1995
Decision Date May 22, 1995
Days to Decision 90 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
20d faster than avg
Panel avg: 110d · This submission: 90d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HQC Device Classification - Class 2, Special Controls

Product Code HQC Unit, Phacofragmentation
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.4670
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HQC Unit, Phacofragmentation

All 122
Devices cleared under the same product code (HQC) and FDA review panel - the closest regulatory comparables to K950798.
STORZ MICROSEAL DP8030 & DP8045 PHACOEMULSIFICATION NEEDLES
K952259 · Storz Instrument Co. · Jun 1995
STOTZ PROTEGE(TM) MICROSURGICAL SYSTEM
K950114 · Storz Instrument Co. · Jun 1995
AOI UNIVERSAL ULTRASONIC HANDPIECE
K950880 · American Optical Corp. · May 1995
VACUUM SURGE SUPRESSER
K950600 · Surgin Surgical Instrumentation, Inc. · May 1995
STORZ PREMIERE(R) MICROSURGICAL SYSTEM
K946227 · Storz Instrument Co. · Mar 1995
IOLAB/SITE DISPOSABLE DIAPHRAGM CASSETTE
K944994 · Chiron Vision Corp. · Mar 1995